Table V.
Association between RIPK2 polymorphisms and gastric mucosal atrophy.
| A, rs16900627, G allele carriers vs. the others | |||||
|---|---|---|---|---|---|
| rs16900627a | AA | AG | GG | AG+GG vs. AA, OR (95% CI) | P-value |
| Non-AT group (232) | 184 | 44 | 4 | Reference | |
| AT group (196) | 134 | 54 | 8 | 1.72 (1.01–2.96) | 0.048 |
| rs16900627, co-variable: the number of G allele | |||||
| B, rs16900627a | AA | AG | GG | No. of G allele, OR (95% CI) | P-value |
| Non-AT group (232) | 184 | 44 | 4 | Reference | |
| AT group (196) | 134 | 54 | 8 | 1.83 (1.14–2.93) | 0.011 |
| C, rs2230801, TC vs. TT | |||||
| rs2230801a | TT | TC | CC | TC vs. TT, OR (95% CI) | P-value |
| Non-AT group (232) | 228 | 4 | 0 | Reference | |
| AT group (196) | 188 | 8 | 0 | 1.70 (0.441–6.99) | 0.472 |
a
The number of subjects following logistic regression analysis after adjustment for age, gender and H. pylori infection status. RIPK2, receptor interacting serine/threonine kinase 2; CI, confidence interval; OR, odds ratio; AT, atrophic gastritis.